NCT02760615View on ClinicalTrials.gov

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 1, 2016

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions
Colitis, UlcerativeCrohn Disease
Interventions
DRUG

Caffeine

Caffeine tablets

DRUG

Losartan

Losartan tablets

DRUG

Omeprazole

Omeprazole capsules

DRUG

Dextromethorphan

Dextromethorphan capsules

DRUG

Midazolam

Midazolam syrup

DRUG

Vedolizumab

Vedolizumab solution for IV infusion

Trial Locations (2)

33143

QPS MRA, Miami

90630

WCCT, Cypress

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY